Literature DB >> 23407094

Atrial fibrillation is associated with increased mortality: causation or association?

Darryl P Leong, John W Eikelboom, Jeff S Healey, Stuart J Connolly.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23407094     DOI： 10.1093/eurheartj/eht044

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  13 in total

Review 1.  Management of atrial fibrillation in bradyarrhythmias.

Authors:  Giuseppe Boriani; Luigi Padeletti
Journal:  Nat Rev Cardiol       Date:  2015-03-17       Impact factor: 32.419

Review 2.  Surgical options in atrial fibrillation.

Authors:  Basel Ramlawi; Kareem Bedeir
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

3.  Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients.

Authors:  Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

4.  New-Onset Atrial Fibrillation in the Critically Ill.

Authors:  Travis J Moss; James Forrest Calland; Kyle B Enfield; Diana C Gomez-Manjarres; Caroline Ruminski; John P DiMarco; Douglas E Lake; J Randall Moorman
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

5.  The study protocol for PREDICT AF RECURRENCE: a PRospEctive cohort stuDy of surveIllanCe for perioperaTive Atrial Fibrillation RECURRENCE in major non-cardiac surgery for malignancy.

Authors:  Satoshi Higuchi; Yusuke Kabeya; Kenichi Matsushita; Keisei Tachibana; Riken Kawachi; Hidefumi Takei; Yutaka Suzuki; Nobutsugu Abe; Yorihisa Imanishi; Kiyoshi Moriyama; Tomoko Yorozu; Koichiro Saito; Masanori Sugiyama; Haruhiko Kondo; Hideaki Yoshino
Journal:  BMC Cardiovasc Disord       Date:  2018-06-26       Impact factor: 2.298

6.  Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.

Authors:  Jennifer R Brown; Javid Moslehi; Susan O'Brien; Paolo Ghia; Peter Hillmen; Florence Cymbalista; Tait D Shanafelt; Graeme Fraser; Simon Rule; Thomas J Kipps; Steven Coutre; Marie-Sarah Dilhuydy; Paula Cramer; Alessandra Tedeschi; Ulrich Jaeger; Martin Dreyling; John C Byrd; Angela Howes; Michael Todd; Jessica Vermeulen; Danelle F James; Fong Clow; Lori Styles; Rudy Valentino; Mark Wildgust; Michelle Mahler; Jan A Burger
Journal:  Haematologica       Date:  2017-07-27       Impact factor: 9.941

7.  Safety and long-term efficacy of thoracoscopic Epicardial ablation in patients with paroxysmal atrial fibrillation: a retrospective study.

Authors:  John Johnkoski; Bryan Miles; Anna Sudbury; Mohammed Osman; Muhammad Bilal Munir; Sudarshan Balla; Mina M Benjamin
Journal:  J Cardiothorac Surg       Date:  2019-11-06       Impact factor: 1.637

Review 8.  Atrial fibrillation in the Indigenous populations of Australia, Canada, New Zealand, and the United States: a systematic scoping review.

Authors:  Judith M Katzenellenbogen; John A Woods; Tiew-Hwa Katherine Teng; Sandra C Thompson
Journal:  BMC Cardiovasc Disord       Date:  2015-08-13       Impact factor: 2.298

9.  Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.

Authors:  Giuseppe Boriani; Raymond Tukkie; Antonis S Manolis; Lluis Mont; Helmut Pürerfellner; Massimo Santini; Giuseppe Inama; Paolo Serra; João de Sousa; Giovanni Luca Botto; Lorenza Mangoni; Andrea Grammatico; Luigi Padeletti
Journal:  Eur Heart J       Date:  2014-04-25       Impact factor: 29.983

10.  Chloride Channels are Involved in the Development of Atrial Fibrillation - A Transcriptomic and proteomic Study.

Authors:  Yi-Yao Jiang; Hai-Tao Hou; Qin Yang; Xiao-Cheng Liu; Guo-Wei He
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.